Multicenter clinical study of immune-cell therapy in patients with malignant tumors.
Not Applicable
- Conditions
- Malignant tumor
- Registration Number
- JPRN-UMIN000019030
- Lead Sponsor
- KOUSHIKAI,Non-profitmedicalcorporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1800
Inclusion Criteria
Not provided
Exclusion Criteria
1) HIV Ab positive. 2) T cell- or NK cell-originated leukemia and/or lymphoma.(LAK therapy) 3)Patients who have previously treated allogenic transplantation. 4) Responsible doctors judged the patient inappropriate for the clinical study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method